cerca CERCA
Martedì 23 Aprile 2024
Aggiornato: 10:37
10 ultim'ora BREAKING NEWS

CHIMICA E FARMACEUTICA

comunicato stampa

Seegene ha dichiarato di aver intenzione di condividere le tecnologie PCR sindromiche per prevenire le pandemie future

SEUL, Corea del Sud, 28 marzo 2023 /PRNewswire/ -- Seegene Inc. (KQ096530), azienda leader nella Corea del Sud che offre una soluzione totale per la diagnostica molecolare PCR, ha annunciato l'inizio della condivisione delle sue tecnologie PCR sindromiche in tutto il mondo. Seegene mira a collaborare con aziende di fama nazionale in ciascun paese, così da sviluppare e produrre a livello locale test PCR sindromici personalizzati tramite l'accesso alle tecnologie e al know-how proprietari di Seegen...

Steriline

Steriline pianifica la stagione 2023: investimenti e fiere di settore

Como, 17/03/2023 - Il direttore commerciale di Steriline, Federico Fumagalli, ha recentemente presentato al mercato il programma delle prossime iniziative aziendali. Forti della crescita continua registrata da Steriline nel settore del primary packaging per il comparto farmaceutico, verrà completato lo stabilimento adiacente all’attuale sede di Como, con l’obiettivo di consolidare il processo di espansione degli spazi adibiti prevalentemente alla produzione.

comunicato stampa

Ajinomoto Bio-Pharma Services Awarded Three 'CDMO Leadership Awards'

SAN DIEGO and TOKYO and WETTEREN, Belgium, March 14, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO Leadership Awards in the categories Capabilities, Compatibility, and Expertise in both the Overall and Big Pharma respondent groups.

comunicato stampa

Maltese Patient Received World's First ND1-LHON Gene Therapy Injection Donated by Neurophth in China

WUHAN, China and SAN DIEGO, March 7, 2023 /PRNewswire/ -- Matthias Szabo Zarb, a Maltese college student, was diagnosed with Leber hereditary optic neuropathy caused by ND1 mutation (ND1-LHON) two years ago, which led to a rapid deterioration in his visual acuity and inability to engage in normal activities. Through the National Alliance for Rare Diseases Support, he learned about NFS-02, a gene therapy drug targeting ND1-LHON which is developed by the Chinese ophthalmic gene therapy company, Neu...

comunicato stampa

Servier receives a positive CHMP opinion for Tibsovo® in IDH1-mutated Acute Myeloid Leukemia (AML) and Cholangiocarcinoma (CCA) patients

PARIS, Feb. 24, 2023 /PRNewswire/ -- Servier, a global pharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization for Tibsovo® (ivosidenib tablets) - an inhibitor of the mutated isocitrate dehydrogenase-1 (IDH1) enzyme - for two indications:

comunicato stampa

Gerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels

DUESSELDORF, Germany, Feb. 23, 2023 /PRNewswire/ -- Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reports double digit growth in revenues and adjusted EBITDA for FY 2022. Revenue rose organically by 16.2%, driven by all divisions. Adjusted EBITDA grew organically by 10.2%. "In 2022, Gerresheimer has proven that it is a profitable growth company, accelerating growth across all businesses. We have exceeded our targe...



SEGUICI SUI SOCIAL



threads whatsapp linkedin twitter youtube facebook instagram
ora in
Prima pagina
articoli
in Evidenza